Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Soleno Therapeutics Inc (SLNO)

Soleno Therapeutics Inc (SLNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Soleno Therapeutics, Inc. Class Action Lawsuit: Investors Face May 5, 2026, Deadline PR Newswire - Thu Apr 2, 5:15PM CDT

Did you buy SLNO common stock between March 26, 2025, and November 4, 202 5?

SLNO : 39.49 (+6.76%)
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Soleno Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - SLNO PR Newswire - Thu Apr 2, 9:00AM CDT

NEW YORK , April 2, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Soleno Therapeutics, Inc. ("Soleno" or the "Company") (NASDAQ: SLNO).   Such...

SLNO : 39.49 (+6.76%)
Soleno Therapeutics, Inc. (SLNO) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit PR Newswire - Wed Apr 1, 3:24PM CDT

LOS ANGELES , April 1, 2026 /PRNewswire/ --  The Law Offices of Frank R. Cruz announces that investors with losses related to Soleno Therapeutics, Inc. ("Soleno" or the "Company") (NASDAQ: ...

SLNO : 39.49 (+6.76%)
Soleno (SLNO) Sued After DCCR Launch Setback, Share Drop-- Hagens Berman PR Newswire - Wed Apr 1, 2:43PM CDT

SAN FRANCISCO , April 1, 2026 /PRNewswire/ -- A securities class action lawsuit has been filed against Soleno Therapeutics, Inc. (NASDAQ: SLNO) seeking to represent investors who purchased Soleno...

SLNO : 39.49 (+6.76%)
SLNO Investor Alert: Soleno Therapeutics, Inc. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Conducting Sham Clinical Trials: Levi & Korsinsky PR Newswire - Wed Apr 1, 8:00AM CDT

Alert: Claims Focus on Alleged Misrepresentations About Clinical Trial Integrity and Drug Safety

SLNO : 39.49 (+6.76%)
SLNO Investors Have Opportunity to Lead Soleno Therapeutics, Inc. Securities Fraud Lawsuit PR Newswire - Tue Mar 31, 9:37PM CDT

NEW YORK , March 31, 2026 /PRNewswire/ --

SLNO : 39.49 (+6.76%)
SLNO Shareholder Alert: Soleno Therapeutics, Inc. Securities Class Action Lawsuit Investors With Losses May Join -- The Gross Law Firm PR Newswire - Tue Mar 31, 8:00AM CDT

NEW YORK , March 31, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of  Soleno Therapeutics, Inc. (NASDAQ: SLNO).

SLNO : 39.49 (+6.76%)
Soleno Therapeutics (SLNO) Faces Securities Class Action Amid Hyperphagia Drug Launch Disruptions -- Hagens Berman PR Newswire - Mon Mar 30, 3:20PM CDT

SLNO Investors with Losses Encouraged to Contact Hagens Berman

SLNO : 39.49 (+6.76%)
SLNO UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Soleno Therapeutics (SLNO) Investors of Securities Class Action Deadline on May 5, 2026 PR Newswire - Sat Mar 28, 9:44AM CDT

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Soleno To Contact Him Directly To Discuss Their Options

SLNO : 39.49 (+6.76%)
Soleno Therapeutics, Inc. Notice of May 5, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline PR Newswire - Fri Mar 27, 9:42PM CDT

NEW YORK and NEW ORLEANS , March 27, 2026 /PRNewswire/ -- Kahn Swick & Foti , LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in ...

SLNO : 39.49 (+6.76%)

Barchart Exclusives

Sysco Just Announced a $29.1 Billion Acquisition and Wall Street Is Nervous. Can a 3% Dividend Sweeten the Deal? Barchart - Thu Apr 2, 6:30PM CDT
The Jetro deal strategically pushes Sysco into a faster‑growing, higher‑margin channel, but the new debt, jumping leverage, share dilution, and negative S&P outlook explain why SYY stock just had its worst day since 2020. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.